Advanced search
Publication Cover
Postgraduate Medicine Volume 123, 2011 - Issue 3
Submit an article Journal homepage
30
Views
5
CrossRef citations to date
0
Altmetric
Clinical Features

Effect of High-Flux Hemodialysis on Delayed Hepatitis B Virus Vaccination Response in Hemodialysis Patients

Qiang He Kidney Disease Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
, MD,
Fuquan Wu Kidney Disease Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
, MD,
Ping Zhang Kidney Disease Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
, MD &
Jianghua Chen Kidney Disease Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, ChinaCorrespondence[email protected]
, MD
Pages 150-152 | Published online: 13 Mar 2015

References

  • . Edey M, Barraclough K, Johnson DW. Review article: Hepatitis B and dialysis. Nephrology (Carlton). 2010;15(2):137–145
  • . Miller ER, Alter MJ, Tokars JI. Protective effect of hepatitis B vaccine in chronic hemodialysis patients. Am J Kidney Dis. 1999;33(2):356–360
  • . Stevens CE, Alter HJ, Taylor PE, Zang EA, Harley EJ, Szmuness W. Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy. N Engl J Med. 1984;311(8):496–501
  • . Chow KM, Law MC, Leung CB, Szeto CC, Li PK. Antibody response to hepatitis B vaccine in end-stage renal disease patients. Nephron Clin Pract. 2006;103(3):c89–c93
  • . Levin A. Dialysis: intradermal HBV vaccination is preferable in nonresponders. Nat Rev Nephrol. 2009;5(11):616–617
  • . Alavian SM, Tabatabaei SV. Effects of oral levamisole as an adjuvant to hepatitis B vaccine in adults with end-stage renal disease: a meta-analysis of controlled clinical trials. Clin Ther. 2010;32(1):1–10
  • . Locatelli F, Martin-Malo A, Hannedouche T,; Membrane Permeability Outcome (MPO) Study Group. Effect of membrane permeability on survival of hemodialysis patients. J Am Soc Nephrol. 2009;20(3):645–654
  • . Fujimori A. Beta-2-microglobulin as a uremic toxin: the Japanese experience. Contrib Nephrol. 2011;168:129–133
  • . Lonnemann G, Novick D, Rubinstein M, Passlick-Deetjen J, Lang D, Dinarello CA. A switch to high-flux helixone membranes reverses suppressed interferon-gamma production in patients on low-flux dialysis. Blood Purif. 2003;21(3):225–231

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.